NASDAQ:TSRO - TESARO News Headlines

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume1.19 million shs
Average Volume1.97 million shs
Market Capitalization$4.13 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.38

Headlines

TESARO (NASDAQ TSRO) News Headlines

Source:
DateHeadline
Global Uterine Cancer Market Spotlight 2017-2026: Key Pipeline Drugs, Clinical Trials, Patent Information, Disease Incidence Forecasts and Licensing and Acquisition Deals - ResearchAndMarkets.com - Business WireGlobal Uterine Cancer Market Spotlight 2017-2026: Key Pipeline Drugs, Clinical Trials, Patent Information, Disease Incidence Forecasts and Licensing and Acquisition Deals - ResearchAndMarkets.com - Business Wire
www.businesswire.com - June 21 at 8:11 AM
Global Uterine Cancer Market to 2026: Sanofi Leads Industry Sponsors, Followed by AstraZeneca and Eli Lilly - PRNewswireGlobal Uterine Cancer Market to 2026: Sanofi Leads Industry Sponsors, Followed by AstraZeneca and Eli Lilly - PRNewswire
www.prnewswire.com - June 20 at 5:19 AM
Pfizers $11 Billion Cancer-Drug Deal Takes Pricey Path to Growth - BloombergPfizer's $11 Billion Cancer-Drug Deal Takes Pricey Path to Growth - Bloomberg
www.bloomberg.com - June 19 at 8:06 AM
Global Uterine Cancer Market Spotlight 2017-2026: Key Pipeline Drugs, Clinical Trials, Patent Information, Disease Incidence Forecasts and Licensing and Acquisition Deals - ResearchAndMarkets.com - Yahoo FinanceGlobal Uterine Cancer Market Spotlight 2017-2026: Key Pipeline Drugs, Clinical Trials, Patent Information, Disease Incidence Forecasts and Licensing and Acquisition Deals - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - June 19 at 8:06 AM
AstraZeneca/Mercks Lynparza Wins EU Nod for First-Line Use - Yahoo FinanceAstraZeneca/Merck's Lynparza Wins EU Nod for First-Line Use - Yahoo Finance
finance.yahoo.com - June 18 at 4:54 PM
Pfizer to boost cancer treatment portfolio with $11.4bn Array deal - Financial TimesPfizer to boost cancer treatment portfolio with $11.4bn Array deal - Financial Times
www.ft.com - June 17 at 10:24 AM
Zai Lab Announces Approval to Commercialize ZEJULA (Niraparib) in Macau for Patients with Relapsed Ovarian Cancer - NasdaqZai Lab Announces Approval to Commercialize ZEJULA (Niraparib) in Macau for Patients with Relapsed Ovarian Cancer - Nasdaq
www.nasdaq.com - June 13 at 8:02 PM
Zai Lab Announces Approval to Commercialize ZEJULA (Niraparib) in Macau for Patients with Relapsed Ovarian Cancer - Yahoo FinanceZai Lab Announces Approval to Commercialize ZEJULA (Niraparib) in Macau for Patients with Relapsed Ovarian Cancer - Yahoo Finance
finance.yahoo.com - June 12 at 8:14 PM
Akrevia Therapeutics Appoints Joseph Farmer as Chief Operating Officer - Yahoo FinanceAkrevia Therapeutics Appoints Joseph Farmer as Chief Operating Officer - Yahoo Finance
finance.yahoo.com - June 12 at 8:14 PM
Mersana Therapeutics Announces Appointment of Brian C. DeSchuytner as Senior Vice President of Finance and Product Strategy - Yahoo FinanceMersana Therapeutics Announces Appointment of Brian C. DeSchuytner as Senior Vice President of Finance and Product Strategy - Yahoo Finance
finance.yahoo.com - June 12 at 8:10 AM
Better Buy: GlaxoSmithKline vs. Merck - Motley FoolBetter Buy: GlaxoSmithKline vs. Merck - Motley Fool
www.fool.com - June 7 at 8:02 AM
Bristol-Myers prescribes US$19bn bond for investors - NasdaqBristol-Myers prescribes US$19bn bond for investors - Nasdaq
www.nasdaq.com - May 8 at 9:41 AM
GSK sees shingles vaccine sales rising, as free cash flow concerns weigh - ReutersGSK sees shingles vaccine sales rising, as free cash flow concerns weigh - Reuters
www.reuters.com - May 3 at 10:00 AM
Glaxo (GSK) Beats on Q1 Earnings & Sales, Shingrix Impresses - NasdaqGlaxo (GSK) Beats on Q1 Earnings & Sales, Shingrix Impresses - Nasdaq
www.nasdaq.com - May 2 at 5:58 PM
3 Top Chinese Stocks to Watch in May - Yahoo Finance3 Top Chinese Stocks to Watch in May - Yahoo Finance
finance.yahoo.com - May 1 at 5:48 PM
Glaxo’s Shingles Vaccine Helps Boost Earnings Over Estimates - BloombergGlaxo’s Shingles Vaccine Helps Boost Earnings Over Estimates - Bloomberg
www.bloomberg.com - May 1 at 9:41 AM
Blockbuster Oncology Brands Market Size Worth $62.80 Billion by 2027: Grand View Research, Inc. - BenzingaBlockbuster Oncology Brands Market Size Worth $62.80 Billion by 2027: Grand View Research, Inc. - Benzinga
www.benzinga.com - April 29 at 9:07 AM
Is a Beat in Store for Glaxo (GSK) This Earnings Season? - NasdaqIs a Beat in Store for Glaxo (GSK) This Earnings Season? - Nasdaq
www.nasdaq.com - April 26 at 5:48 PM
Heres What Hedge Funds Think About Compania de Minas Buenaventura SA (BVN) - Yahoo FinanceHere's What Hedge Funds Think About Compania de Minas Buenaventura SA (BVN) - Yahoo Finance
finance.yahoo.com - April 25 at 5:57 PM
Here’s What Hedge Funds Think About Eaton Vance Corp (EV) - Yahoo FinanceHere’s What Hedge Funds Think About Eaton Vance Corp (EV) - Yahoo Finance
finance.yahoo.com - April 25 at 5:57 PM
Here’s What Hedge Funds Think About Portland General Electric Company (POR) - Yahoo FinanceHere’s What Hedge Funds Think About Portland General Electric Company (POR) - Yahoo Finance
finance.yahoo.com - April 25 at 5:57 PM
Heres What Hedge Funds Think About VEON Ltd. (VEON) - Yahoo FinanceHere's What Hedge Funds Think About VEON Ltd. (VEON) - Yahoo Finance
finance.yahoo.com - April 25 at 5:57 PM
GSK cutting employees at its R&D unit in Collegeville - Philadelphia Business JournalGSK cutting employees at its R&D unit in Collegeville - Philadelphia Business Journal
www.bizjournals.com - April 19 at 5:34 PM
Allena Pharmaceuticals Appoints Allene Diaz to its Board of Directors - NasdaqAllena Pharmaceuticals Appoints Allene Diaz to its Board of Directors - Nasdaq
www.nasdaq.com - April 17 at 11:33 AM
AstraZeneca/Mercks Lynparza Wins EU Nod for Breast Cancer - NasdaqAstraZeneca/Merck's Lynparza Wins EU Nod for Breast Cancer - Nasdaq
www.nasdaq.com - April 10 at 5:55 PM
Health Day Checkup of Medical ETFs: 5 Top Picks - NasdaqHealth Day Checkup of Medical ETFs: 5 Top Picks - Nasdaq
www.nasdaq.com - April 5 at 5:34 PM
Westlake Village BioPartners Beth Seidenberg Named One of Worlds Top Venture Capitalists - PRNewswireWestlake Village BioPartners' Beth Seidenberg Named One of World's Top Venture Capitalists - PRNewswire
www.prnewswire.com - April 2 at 1:00 PM
Who OPKO Health Is Tanking TodayWho OPKO Health Is Tanking Today
finance.yahoo.com - February 28 at 5:29 PM
Beryl Capital Management’s Returns, AUM, and HoldingsBeryl Capital Management’s Returns, AUM, and Holdings
finance.yahoo.com - February 22 at 10:32 AM
BioPharma Credit To Receive Tesaro Loan Payment After GSK AcquisitionBioPharma Credit To Receive Tesaro Loan Payment After GSK Acquisition
www.morningstar.co.uk - January 23 at 9:22 AM
GSK (GSK) completes acquisition of TESARO (TSRO) - StreetInsider.comGSK (GSK) completes acquisition of TESARO (TSRO) - StreetInsider.com
www.streetinsider.com - January 22 at 5:26 PM
Form 8-K TESARO, Inc. For: Jan 22 - StreetInsider.comForm 8-K TESARO, Inc. For: Jan 22 - StreetInsider.com
www.streetinsider.com - January 22 at 5:26 PM
Form SC TO-T/A TESARO, Inc. Filed by: GLAXOSMITHKLINE PLC - StreetInsider.comForm SC TO-T/A TESARO, Inc. Filed by: GLAXOSMITHKLINE PLC - StreetInsider.com
www.streetinsider.com - January 16 at 5:31 PM
GlaxoSmithKline Extends Expiration Date For Tesaro Tender OfferGlaxoSmithKline Extends Expiration Date For Tesaro Tender Offer
www.morningstar.co.uk - January 15 at 9:10 AM
4 Biotech Pipeline Areas To Keep An Eye On In 20194 Biotech Pipeline Areas To Keep An Eye On In 2019
feeds.benzinga.com - January 11 at 4:41 PM
WEDNESDAY DEADLINE REMINDER: The Schall Law Firm Announces It is Investigating Claims against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmWEDNESDAY DEADLINE REMINDER: The Schall Law Firm Announces It is Investigating Claims against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - January 8 at 8:55 AM
Cancer stocks heat up after third big merger in the past month - MarketWatchCancer stocks heat up after third big merger in the past month - MarketWatch
www.marketwatch.com - January 7 at 5:58 PM
Glaxos CEO Set to Highlight Cancer Ambitions With Key Drugs - BloombergGlaxo's CEO Set to Highlight Cancer Ambitions With Key Drugs - Bloomberg
www.bloomberg.com - January 7 at 5:58 PM
SINGLE TICKER NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Tesaro, Inc. - TSROSINGLE TICKER NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Tesaro, Inc. - TSRO
finance.yahoo.com - January 3 at 5:28 PM
DEADLINE NEXT WEEK: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmDEADLINE NEXT WEEK: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
feeds.benzinga.com - January 1 at 3:40 PM
TSRO Dec 2018 14.000 putTSRO Dec 2018 14.000 put
finance.yahoo.com - December 29 at 8:19 AM
TSRO LOSS NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Tesaro, Inc.; Important Case Deadline – TSROTSRO LOSS NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Tesaro, Inc.; Important Case Deadline – TSRO
finance.yahoo.com - December 29 at 8:19 AM
ONE DEADLINE ALERT: Pawar Law Group Reminds of Deadline in Securities Class Action Lawsuit Against Tesaro, Inc. - TSROONE DEADLINE ALERT: Pawar Law Group Reminds of Deadline in Securities Class Action Lawsuit Against Tesaro, Inc. - TSRO
finance.yahoo.com - December 28 at 5:35 PM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COST, RBBN, TSRO and MGIThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COST, RBBN, TSRO and MGI
globenewswire.com - December 23 at 5:26 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline - TSROSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline - TSRO
finance.yahoo.com - December 22 at 8:20 AM
TSRO INVESTOR ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Tesaro, Inc.; Important Deadline – TSROTSRO INVESTOR ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Tesaro, Inc.; Important Deadline – TSRO
finance.yahoo.com - December 19 at 8:23 AM
Here is What Hedge Funds Think About Tesaro Inc (TSRO)Here is What Hedge Funds Think About Tesaro Inc (TSRO)
finance.yahoo.com - December 16 at 5:32 PM
READ NOW: Monteverde & Associates PC Is Investigating The Tender Offer Of Tesaro, Inc. Set To Expire On January 14, 2019 - TSROREAD NOW: Monteverde & Associates PC Is Investigating The Tender Offer Of Tesaro, Inc. Set To Expire On January 14, 2019 - TSRO
finance.yahoo.com - December 14 at 5:17 PM
DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmDEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - December 14 at 8:11 AM
Tesaro Expects These Key Research Pipeline Milestones in 2019Tesaro Expects These Key Research Pipeline Milestones in 2019
finance.yahoo.com - December 13 at 9:32 AM
This page was last updated on 6/26/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel